4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Liquidia Corporation (LQDA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Morrisville, United States with about 216 employees. Its market capitalization is roughly $7 billion. In the fiscal year ended 2025-12-31, LQDA reported $158M in revenue and ($69M) in net income.
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
Interactive charts & full statements → Open the LQDA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $158M | $14M | $18M | $16M | — |
| Gross Profit | $145M | $8M | $15M | $13M | — |
| Operating Income (EBIT) | ($51M) | ($121M) | ($73M) | ($39M) | — |
| Net Income | ($69M) | ($128M) | ($78M) | ($41M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $133M | $92M | $54M | $9M | $3M | — |
| Gross Profit | $121M | $85M | $51M | $7M | $2M | — |
| Operating Income (EBIT) | $62M | $20M | $2M | ($38M) | ($35M) | — |
| Net Income | $53M | $15M | ($4M) | ($42M) | ($38M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $328M | $230M | $118M | $129M | — |
| Total Liabilities | $283M | $151M | $71M | $39M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LQDA viewer.
About TickerBase · Data methodology & sources